BIOF on OTC
BLUE BIOFUELS, INC.
BLUE BIOFUELS, INC. is an American industrial organic chemicals company based in Palm Beach Gardens.1
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with Quantum Genesis AI Corp., GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES or SUIC Worldwide Holdings Ltd., or pick any stock.
- TickerBIOF on OTC1
- IndustryIndustrial Organic Chemicals1
- HeadquartersPalm Beach Gardens, Florida1
- Incorporated inNV2
- Business address3710 Buckeye St, Suite 120, Palm Beach Gardens, Fl 334012
- Filer categoryNon-accelerated filer, Smaller reporting company2
- Legal formCorporation
See how the biggest companies compare on our leaderboards
Inc. (the “Company”) has been a technology company focused on emerging technologies in renewable energy, biofuels, and lignin.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2019
Where the money goes
Where each dollar of revenue went, fiscal 2019
- Research and development44¢$797.9K
- Profit56¢$1.0M
Out of $60.0K in revenue.4
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.7
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| General and administrative | $1.4M | $1.7M |
| Research and development | $2.3M | $2.3M |
| Loss on disposal of assets | $1.4K | |
| Total operating expenses | $3.7M | $4.1M |
| Loss from operations: | -$3.7M | -$4.1M |
| Grants Income | -$865.0K | -$285.0K |
| Gain on extinguishment of debt | -$2.4M | |
| Interest expensed or (earned) - other | -$9 | $9.9K |
| Total other (income) expense | -$840.5K | -$2.6M |
| Income (Loss) before provisions for income taxes | -$2.9M | -$1.4M |
| Net Income (Loss): | -$2.9M | -$1.4M |
| Net income (loss) per share - basic | -$0.01 | -$0.01 |
| Net income (loss) per share - diluted | -$0.01 | -$0.01 |
| Basic | 312.2M shares | 303.9M shares |
| Diluted | 312.2M shares | 303.9M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and Cash Equivalents | $65.2K | $48.8K | |
| Prepaid Expenses | $11.6K | $32.5K | |
| TOTAL CURRENT ASSETS | $76.8K | $81.3K | |
| Property and Equipment, net of accumulated depreciation and amortization of $482,578 and $361,887 at December 31, 2025 and December 31, 2024, respectively | $555.1K | $539.6K | |
| Deposits | $80.3K | $30.3K | |
| Right of Use Assets, net of accumulated amortization | $365.4K | $440.3K | |
| Patents and Trademarks, net of accumulated amortization | $329.8K | $298.1K | |
| TOTAL OTHER ASSETS | $1.3M | $1.3M | |
| TOTAL ASSETS | $1.4M | $1.4M | |
| Right of Use Lease Liability - Current | $79.3K | $68.7K | |
| Interest Payable - Related Party | $176.5K | $185.7K | |
| TOTAL CURRENT LIABILITIES | $3.0M | $2.2M | |
| Right of Use Lease Liability, Long Term | $293.4K | $372.7K | |
| Legacy Notes Payable | $320.6K | $320.6K | |
| TOTAL LONG TERM LIABILITIES | $2.1M | $2.0M | |
| TOTAL LIABILITIES | $5.1M | $4.2M | |
| Common stock; $0.001 par value; 1,000,000,000 shares authorized; 317,872,112 issued and outstanding at December 31, 2025, and 307,960,508 issued and outstanding at December 31, 2024. | $317.9K | $308.0K | |
| Additional paid-in capital | $56.1M | $54.1M | |
| Accumulated deficit | -$60.1M | -$57.3M | |
| TOTAL STOCKHOLDERS DEFICIT | -$3.7M | -$2.8M | -$3.6M |
| TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT | $1.4M | $1.4M | |
| Property and equipment, net of accumulated depreciation and amortization | $482.6K | $361.9K | |
| Preferred stock, par value | $0.00 | $0.00 | |
| Preferred stock, shares authorized | 10.0M shares | 10.0M shares | |
| Preferred stock, shares issued | 0 shares | 0 shares | |
| Preferred stock, shares outstanding | 0 shares | 0 shares | |
| Common stock, par value | $0.00 | $0.00 | |
| Common stock, shares authorized | 1.0B shares | 1.0B shares | |
| Common stock, shares issued | 317.9M shares | 308.0M shares | |
| Common stock, shares outstanding | 317.9M shares | 308.0M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and Cash Equivalents | $65.2K | $48.8K | |
| Prepaid Expenses | $11.6K | $32.5K | |
| TOTAL CURRENT ASSETS | $76.8K | $81.3K | |
| Property and Equipment, net of accumulated depreciation and amortization of $482,578 and $361,887 at December 31, 2025 and December 31, 2024, respectively | $555.1K | $539.6K | |
| Deposits | $80.3K | $30.3K | |
| Right of Use Assets, net of accumulated amortization | $365.4K | $440.3K | |
| Patents and Trademarks, net of accumulated amortization | $329.8K | $298.1K | |
| TOTAL OTHER ASSETS | $1.3M | $1.3M | |
| TOTAL ASSETS | $1.4M | $1.4M | |
| Right of Use Lease Liability - Current | $79.3K | $68.7K | |
| Interest Payable - Related Party | $176.5K | $185.7K | |
| TOTAL CURRENT LIABILITIES | $3.0M | $2.2M | |
| Right of Use Lease Liability, Long Term | $293.4K | $372.7K | |
| Legacy Notes Payable | $320.6K | $320.6K | |
| TOTAL LONG TERM LIABILITIES | $2.1M | $2.0M | |
| TOTAL LIABILITIES | $5.1M | $4.2M | |
| Common stock; $0.001 par value; 1,000,000,000 shares authorized; 317,872,112 issued and outstanding at December 31, 2025, and 307,960,508 issued and outstanding at December 31, 2024. | $317.9K | $308.0K | |
| Additional paid-in capital | $56.1M | $54.1M | |
| Accumulated deficit | -$60.1M | -$57.3M | |
| TOTAL STOCKHOLDERS DEFICIT | -$3.7M | -$2.8M | -$3.6M |
| TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT | $1.4M | $1.4M | |
| Property and equipment, net of accumulated depreciation and amortization | $482.6K | $361.9K | |
| Preferred stock, par value | $0.00 | $0.00 | |
| Preferred stock, shares authorized | 10.0M shares | 10.0M shares | |
| Preferred stock, shares issued | 0 shares | 0 shares | |
| Preferred stock, shares outstanding | 0 shares | 0 shares | |
| Common stock, par value | $0.00 | $0.00 | |
| Common stock, shares authorized | 1.0B shares | 1.0B shares | |
| Common stock, shares issued | 317.9M shares | 308.0M shares | |
| Common stock, shares outstanding | 317.9M shares | 308.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.7
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net Income (Loss) | -$2.9M | -$1.4M |
| Depreciation and amortization | $145.9K | $118.8K |
| Stock based compensation | $1.0M | $1.7M |
| Extinguishment of debt | -$2.4M | |
| Issuance of warrants for interest expense | $24.5K | $12.4K |
| Loss on Disposal of assets | $1.4K | |
| Prepaid expenses | $20.9K | $3.3K |
| Accounts payable | -$66.1K | $200.6K |
| Accounts payable - related party | -$24.1K | |
| Deferred wages and directors fees - related party | $917.3K | $779.6K |
| Interest payable - related party | -$9.2K | $42.3K |
| Net cash used in operating activities | -$845.0K | -$1.0M |
| Purchase of property and equipment | -$68.9K | -$71.1K |
| Payment of deposits on property | -$50.0K | |
| Additions to patent and trademark costs | -$18.4K | -$44.7K |
| Net cash from (used in) investing activities | -$137.3K | -$115.8K |
| Proceeds from issuance of common stock | $745.0K | $197.0K |
| Proceeds from the issuance of convertible notes - RP | $185.0K | $680.0K |
| Proceeds from the issuance of convertible notes - Other | $250.0K | |
| Proceeds from exercise of warrants | $68.8K | |
| Net cash provided by financing activities | $998.8K | $1.1M |
| Net increase (decrease) in cash and cash equivalents | $16.4K | $7.8K |
| Recognition of operating lease liability and right-of-use asset | $452.1K | |
| Issuance of common stock for patent and trademark costs | $38.5K | |
| Issuance of common stock for property and equipment | $67.3K | |
| Issuance of common stock and warrants on the conversion of notes payable | $50.0K | $250.0K |
No quarter-by-quarter statement was filed.
Corporate structure
BLUE BIOFUELS, INC. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of BLUE BIOFUELS, INC.
- Christopher J. Jemapete Filed SC 13G/A on BLUE BIOFUELS, INC., latest Feb 3, 2023 (2 filings since Jan 24, 2022)
- Chris J. Kneppers Filed SC 13G on BLUE BIOFUELS, INC., latest May 10, 2022
- BLUE BIOFUELS, INC. Palm Beach Gardens, Florida
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What BLUE BIOFUELS, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $1.0M7 Dec 31, 2025 | $901.5K7 Dec 31, 2024 | +15.1% |
| Accumulated depreciation | $482.6K7 Dec 31, 2025 | $361.9K7 Dec 31, 2024 | +33.4% |
| Property and equipment, net | $555.1K7 Dec 31, 2025 | $539.6K7 Dec 31, 2024 | +2.9% |
| Operating-lease assets (leased space) | $365.4K7 Dec 31, 2025 | $440.3K7 Dec 31, 2024 | −17.0% |
Real estate and locations
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $65.2K7 Dec 31, 2025 | $48.8K7 Dec 31, 2024 | +33.6% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Finite-lived intangibles, gross | $329.8K7 Dec 31, 2025 | $298.1K7 Dec 31, 2024 | +10.7% |
| Accumulated amortization | $25.2K7 Dec 31, 2025 | $07 Dec 31, 2024 | |
| Finite-lived intangibles, net | $61.1K7 Dec 31, 2025 | ||
| Patents, net | $298.1K9 Dec 31, 2024 | $254.8K9 Dec 31, 2023 | +17.0% |
Properties, in its own words
Offices
The Company maintains its corporate office at 3710 Buckeye Street, Suite 120, Palm Beach Gardens 33410. The Company’s telephone number is 888-607-3555. On August 30, 2019, the Company signed a lease for a period of twenty-four (24) months from November 1, 2019, through October 31, 2021. In December 2020, this lease was extended for twelve (12) months, and in August 2022, extended the lease for two more years until October 31, 2024. The most recent extension is until October 31, 2029. Annual rent in the latest lease extension commenced at approximately $109,205 per annum and increases on a year-to-year basis by three percent (3%) over the base year. In addition, the Company is obligated to pay an amount equal to 10.41% of the operating expenses of the building together with sales tax on all amounts. This office space includes the Company’s research and demonstration facilities.
Item 2 of the 10-K filed Mar 19, 2026.3
Leadership
Who has led BLUE BIOFUELS, INC., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerBenjamin Slager Feb 3, 2021 to Dec 31, 202410
- Chief executive officerLiege Daniel De Mar 12, 2014 to Jul 17, 201411
- PresidentLiege Daniel De Mar 12, 2014 to Mar 10, 201611
- Chief financial officerRichard Cohen Mar 12, 2014 to Mar 12, 201412
Board members and other officers (12)
- SecretaryGeorge Bolton Jan 15, 2021 to Jan 15, 202113
- Board memberChris J. Kneppers Sep 28, 2022 to now14
- Board memberBenjamin Slager Feb 3, 2021 to Dec 31, 202410
- Board memberEdmund J. Burke Mar 9, 2021 to Jan 31, 202315
- Board memberPeter Zimeri Apr 6, 2021 to Apr 6, 202116
- Board memberCharles Sills Nov 25, 2015 to Mar 8, 202117
- Board memberGeorge Bolton Nov 25, 2015 to Jan 10, 202518
- Board memberJoseph McNaney Mar 12, 2014 to Aug 7, 201419
- Board memberLiege Daniel De Mar 12, 2014 to Mar 10, 201611
- Board memberMark W. Koch Mar 12, 2014 to Mar 10, 201620
- Board memberTed Chasanoff Mar 12, 2014 to Mar 12, 201421
- Board memberW. Johan Sturm Mar 19, 2014 to Mar 19, 201422
Named in SEC Form D filings
People the company listed in its private-offering notices.
- Executive Officer, DirectorAnthony Joseph Santelli II named Jan 26, 2022 to Jun 26, 202623
Former names
Timeline
- Jun 9, 20268-K Change of auditor24
- May 17, 20248-K Change of auditor25
- Jan 24, 20248-K Other events26
- May 25, 20238-K Change of auditor27
- Sep 29, 20228-K Executive or director change28
- Dec 15, 20218-K Other events29
- Feb 3, 2021New chief executive Benjamin Slager becomes CEO10
- Mar 12, 2014New chief executive Liege Daniel De becomes CEO11
Filings
61 filings to the SEC since October 2021: 6 annual reports, 16 quarterly reports, 6 major events, 14 insider forms, 3 large holders, 8 private raises, 8 other. The latest 20:
- Oct 15, 20264 EDGAR
- Oct 13, 2026144 EDGAR
- Sep 8, 20264 EDGAR
- Sep 3, 20264 EDGAR
- Sep 3, 2026144 EDGAR
- Aug 10, 202610-Q EDGAR
- Jun 26, 2026D/A EDGAR
- Jun 9, 20268-K EDGAR
- May 4, 202610-Q EDGAR
- Mar 19, 202610-K EDGAR
- Dec 5, 2025D EDGAR
- Oct 23, 202510-Q EDGAR
- Jul 31, 202510-Q EDGAR
- Apr 30, 202510-Q EDGAR
- Mar 19, 202510-K EDGAR
- Jan 10, 20255 EDGAR
- Jan 10, 20254 EDGAR
- Dec 31, 20244 EDGAR
- Dec 31, 20244 EDGAR
- Dec 23, 2024D EDGAR
The 61 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
7 open-market trades by officers, directors and large owners since October 2021: 2 buys and 5 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Kneppers Chris JDirector | Sale | 300,000 | $0.10 | $30.0K | Form 4 |
| Sep 4, 2026 | Kneppers Chris JDirector | Sale | 200,000 | $0.10 | $20.0K | Form 4 |
| Sep 3, 2026 | Kneppers Chris JDirector | Sale | 100,000 | $0.10 | $10.0K | Form 4 |
| Sep 2, 2026 | Kneppers Chris JDirector | Sale | 700,000 | $0.09 | $63.0K | Form 4 |
| Sep 1, 2026 | Kneppers Chris JDirector | Sale | 200,000 | $0.09 | $18.0K | Form 4 |
| May 2, 2022 | Santelli Anthony IIChief Financial Officer | Buy | 500,000 | $0.15 | $75.0K | Form 4 |
| Apr 27, 2022 | Slager BenjaminChief Executive Officer | Buy | 500,000 | $0.15 | $75.0K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Christopher J. JemapeteSC 13G/A, 2 filings Jan 24, 2022 to Feb 3, 202330
- Chris J. KneppersSC 13G, 1 filing May 10, 202231
Funding
Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.
- Private raises (Form D) $4.9M
Figures by year
| Year | Private raises (Form D) | Total |
|---|---|---|
| 2025 | $587.0K | $587.0K |
| 2024 | $197.0K | $197.0K |
| 2022 | $2.0M | $2.0M |
| 2021 | $2.1M | $2.1M |
Private raises
Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.
- Nov 10, 2025Raised $587,000 in a private offering of equity23 Form D: 11 investors so far Form D
- Nov 14, 2024Raised $197,000 in a private offering of equity32 Form D: 5 investors so far Form D
- Oct 21, 2022Raised $1.1 million in a private offering of equity33 Form D: 25 investors so far Form D
- May 2, 2022Raised $915,000 in a private offering of equity34 Form D: 12 investors so far Form D
- Jan 25, 2021Raised $2.1 million in a private offering of equity35 Form D: 43 investors so far Form D
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Ancora Advisors LLC | 280,369 | $33.6K | 0.0% | No change |
| Atlas Wealth LLC | 24,300 | $2.9K | 0.0% | No change |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How BLUE BIOFUELS, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARBLUE BIOFUELS, INC.1
- CIK0001549145
- Employer ID (EIN)45-49449603
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; a shell company3
- Incorporated inNevada3
- Fiscal year endsDecember 311
- Industry code (SIC)2860 Industrial Organic Chemicals1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address3710 Buckeye St, Suite 120, Palm Beach Gardens, FL 334011
- Phone(888)607-35551
- Shares outstanding324,168,980 as of Aug 9, 20266
- Public float$32.6M as of Jun 30, 20253
- AuditorAssure CPA, LLC, Spokane, Washington PCAOB ID 444; no auditor attestation of internal control over financial reporting3
- On EDGAR sinceMay 23, 20121
- Filings291 in all: 4 (42), 8-K (39), 10-Q (35), 3 (20), SC 13D/A (20), UPLOAD (18), CORRESP (15), 10-K (12)1
All 34 form types
10-Q/A (11), 4/A (10), D (9), NT 10-K (6), NT 10-Q (5), 10-12G/A (4), 10-K/A (4), 144 (4), D/A (4), S-1/A (4), SC 13D (4), DEF 14C (3), PRE 14C (3), SC 13G/A (3), DEF 14A (2), PRE 14A (2), S-1 (2), SC 13G (2), 10-12G (1), 15-12G (1), 5 (1), 8-A12G (1), 8-K/A (1), EFFECT (1), NT 10-K/A (1), RW (1)
- Latest filingsAnnual report (10-K) Mar 19, 2026
Quarterly report (10-Q) Aug 10, 2026
Proxy statement (DEF 14A) May 24, 2016
Latest 8-K (8-K) Jun 9, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock par value $0.001 | BIOF |
From the cover page of the 10-K filed Mar 19, 2026 (Section 12(b) of the Exchange Act).3
Risk factors and legal proceedings
Legal proceedings
The Company is subject, from time to time, to litigation, claims and suits arising in the ordinary course of business. As of the date of filing, there are no material claims or suits whose outcomes could have a material effect on the Company’s financial statements.
The opening of Item 3, Legal Proceedings.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARGeorge Bolton, Secretary
- 14SEC EDGARChris J. Kneppers, Board member
- 15SEC EDGAREdmund J. Burke, Board member
- 16SEC EDGARPeter Zimeri, Board member
- 17SEC EDGARCharles Sills, Board member
- 18SEC EDGARGeorge Bolton, Board member
- 19SEC EDGARJoseph McNaney, Board member
- 20SEC EDGARMark W. Koch, Board member
- 21SEC EDGARTed Chasanoff, Board member
- 22SEC EDGARW. Johan Sturm, Board member
- 23
- 24SEC EDGARChange of auditor
- 25SEC EDGARChange of auditor
- 26SEC EDGAROther events
- 27SEC EDGARChange of auditor
- 28SEC EDGARExecutive or director change
- 29SEC EDGAROther events
- 30
- 31
- 32
- 33
- 34
- 35